COM902 is a human IgG4 monoclonal antibody (mAb) targeting TIGIT, designed to boost antitumor immune responses. It is applicable in research related to multiple myeloma, solid tumors, and colorectal cancer. The recommended isotype control is IgG4-lambda.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
